FNDC5 and coronary artery disorder: Irisin has displayed to decrease in people with T2DM and macrovascular complications such as coronary artery disease and peripheral vascular and cardiovascular disease, compared to patients without macrovascular complications, proposing this myosin as a possible marker of macrovascular disease in people with T2DM [29].